MX5839A - Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida, producto obtenido y composicion farmaceutica que lo incluye. - Google Patents
Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida, producto obtenido y composicion farmaceutica que lo incluye.Info
- Publication number
- MX5839A MX5839A MX583985A MX583985A MX5839A MX 5839 A MX5839 A MX 5839A MX 583985 A MX583985 A MX 583985A MX 583985 A MX583985 A MX 583985A MX 5839 A MX5839 A MX 5839A
- Authority
- MX
- Mexico
- Prior art keywords
- oxindol
- carboxamide
- procedure
- compound
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60735684A | 1984-05-04 | 1984-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX5839A true MX5839A (es) | 1993-11-01 |
Family
ID=24431933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX583985A MX5839A (es) | 1984-05-04 | 1985-05-03 | Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida, producto obtenido y composicion farmaceutica que lo incluye. |
Country Status (25)
| Country | Link |
|---|---|
| JP (1) | JPS60243068A (es) |
| KR (1) | KR870000497B1 (es) |
| AR (1) | AR241159A1 (es) |
| BG (2) | BG60208B2 (es) |
| CS (1) | CS252828B2 (es) |
| DD (1) | DD232916A5 (es) |
| EG (1) | EG17193A (es) |
| ES (2) | ES8609248A1 (es) |
| FI (1) | FI80016C (es) |
| HU (1) | HU196057B (es) |
| IE (1) | IE851103L (es) |
| IN (1) | IN161509B (es) |
| MA (1) | MA20424A1 (es) |
| MW (1) | MW1685A1 (es) |
| MX (1) | MX5839A (es) |
| NO (1) | NO163132C (es) |
| OA (1) | OA08098A (es) |
| PL (2) | PL145416B1 (es) |
| PT (1) | PT80375B (es) |
| RO (2) | RO94455B (es) |
| RU (1) | RU2017729C1 (es) |
| SU (1) | SU1468413A3 (es) |
| YU (1) | YU44998B (es) |
| ZA (1) | ZA853324B (es) |
| ZW (1) | ZW7885A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| IL95880A (en) * | 1989-10-13 | 1995-12-31 | Pfizer | Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis |
-
1985
- 1985-04-08 IN IN288/DEL/85A patent/IN161509B/en unknown
- 1985-04-30 PT PT80375A patent/PT80375B/pt unknown
- 1985-04-30 YU YU730/85A patent/YU44998B/xx unknown
- 1985-05-02 DD DD85275898A patent/DD232916A5/de not_active IP Right Cessation
- 1985-05-02 AR AR300259A patent/AR241159A1/es active
- 1985-05-02 JP JP60095275A patent/JPS60243068A/ja active Granted
- 1985-05-02 EG EG275/85A patent/EG17193A/xx active
- 1985-05-02 IE IE851103A patent/IE851103L/xx unknown
- 1985-05-03 MW MW16/85A patent/MW1685A1/xx unknown
- 1985-05-03 ES ES542813A patent/ES8609248A1/es not_active Expired
- 1985-05-03 OA OA58583A patent/OA08098A/xx unknown
- 1985-05-03 ZA ZA853324A patent/ZA853324B/xx unknown
- 1985-05-03 RO RO123678A patent/RO94455B/ro unknown
- 1985-05-03 BG BG70071A patent/BG60208B2/xx unknown
- 1985-05-03 KR KR1019850003013A patent/KR870000497B1/ko not_active IP Right Cessation
- 1985-05-03 PL PL1985253203A patent/PL145416B1/pl unknown
- 1985-05-03 NO NO851774A patent/NO163132C/no not_active IP Right Cessation
- 1985-05-03 RO RO118604A patent/RO91141B/ro unknown
- 1985-05-03 FI FI851756A patent/FI80016C/fi not_active IP Right Cessation
- 1985-05-03 PL PL1985257892A patent/PL147508B1/pl unknown
- 1985-05-03 MA MA20648A patent/MA20424A1/fr unknown
- 1985-05-03 MX MX583985A patent/MX5839A/es unknown
- 1985-05-03 ZW ZW78/85A patent/ZW7885A1/xx unknown
- 1985-05-04 CS CS853202A patent/CS252828B2/cs not_active IP Right Cessation
- 1985-05-04 RU SU853891002A patent/RU2017729C1/ru active
- 1985-05-31 HU HU851693A patent/HU196057B/hu unknown
-
1986
- 1986-01-27 ES ES551275A patent/ES8707182A1/es not_active Expired
- 1986-05-12 SU SU864027453A patent/SU1468413A3/ru active
-
1992
- 1992-07-08 BG BG96583A patent/BG60207B2/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX22877A (es) | Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye | |
| IT8421343A0 (it) | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti. | |
| MX5723A (es) | Procedimiento para la preparacion de n-tiazolimetiltio-alquil-n`-alquilamidinas producto obtenido y composicion farmaceutica que lo incluye | |
| ES544644A0 (es) | Un procedimiento para la preparacion de derivados de carboxamidoadenosina. | |
| ES541336A0 (es) | Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofen. | |
| ES540901A0 (es) | Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos. | |
| EP0157346A3 (en) | Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same | |
| ES542703A0 (es) | Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos. | |
| ES546236A0 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
| ES539822A0 (es) | Procedimiento para la preparacion de pirazolopiridinas. | |
| ES540609A0 (es) | Un procedimiento para la preparacion de pirazolo piridinas. | |
| MX14310A (es) | Procedimiento para la preparacion de nuevos agentes antiarritmicos, producto obtenido y preparacion farmaceutica que lo incluye. | |
| ES550504A0 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
| ES542840A0 (es) | Procedimiento para la preparacion de un producto fibroso no tejido. | |
| MX3375A (es) | Procedimiento de preparacion de nuevas benzamidas y sus sales, producto obtenido y composicion farmaceutica que lo incluye. | |
| ES553868A0 (es) | Un procedimiento para la preparacion de epidofilotaxina y compuestos relacionados. | |
| MX11493A (es) | Procedimiento para la preparacion de derivados de pirimidina y producto obtenido. | |
| ES553125A0 (es) | Procedimiento para la preparacion de un producto granulado | |
| BR8700805A (pt) | Processo para a preparacao de compostos macrolideos,processo para combater pragas,e,processo para a preparacao de uma composicao para combater pragas | |
| MX9173A (es) | Procedimiento para la preparacion de compuestos anionicos ciclo-diilidicos y producto obtenido. | |
| MX5839A (es) | Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida, producto obtenido y composicion farmaceutica que lo incluye. | |
| MX9203736A (es) | Procedimiento para la preparacion de vitamina d2 1-alfa, 25-dihidroxilada y compuestos relacionados. | |
| ES548244A0 (es) | Un procedimiento para la preparacion de derivados de 5-cetomilbemicina. | |
| ES540132A0 (es) | Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas. | |
| ES547438A0 (es) | Un procedimiento para la preparacion de derivados de carbaprem. |